Elevated I-MIBG Activity in Adrenocortical Adenoma-what Other Imaging Options Do We Have?

Overview

Journal Quant Imaging Med Surg

Specialty Radiology

Date 2022 Apr 4

PMID 35371959

Authors

Xiaotian Xia

Keshan Wang

Fuqiang Shao

Fan Hu

Shengqing Hu

Yu Dai

Yongxue Zhang

Xiaoli Lan

Affiliations

Soon will be listed here.

References

Bourdeau I, El Ghorayeb N, Gagnon N, Lacroix A . MANAGEMENT OF ENDOCRINE DISEASE: Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas. Eur J Endocrinol. 2018; 179(2):R57-R67. DOI: 10.1530/EJE-18-0296. View

Sato H, Igarashi H, Kishimoto Y, Yamaguchi K, Saito T, Ishida H . Combined tumor consisting of non-functioning adrenocortical adenoma and pheochromocytoma in the same gland. Int J Urol. 2002; 9(7):398-401. DOI: 10.1046/j.1442-2042.2002.00482.x. View

Sone H, Okuda Y, Nakamura Y, Ishikawa N, Yamaoka T, Kawakami Y . Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma. A false-positive case of adrenocortical adenoma and literature review. Horm Res. 1996; 46(3):138-42. DOI: 10.1159/000185010. View

Corwin M, Navarro S, Malik D, Loehfelm T, Fananapazir G, Wilson M . Differences in Growth Rate on CT of Adrenal Adenomas and Malignant Adrenal Nodules. AJR Am J Roentgenol. 2019; 213(3):632-636. DOI: 10.2214/AJR.19.21342. View

Pappachan J, Tun N, Arunagirinathan G, Sodi R, Hanna F . Pheochromocytomas and Hypertension. Curr Hypertens Rep. 2018; 20(1):3. DOI: 10.1007/s11906-018-0804-z. View

Sone H, Okuda Y, Nakamura Y, Ishikawa H, Yamaoka T, Kawakami Y . Pitfalls in scanning for phaeochromocytoma. Lancet. 1994; 344(8920):476-7. DOI: 10.1016/s0140-6736(94)91809-0. View

Vallabhajosula S, Nikolopoulou A . Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology. Semin Nucl Med. 2011; 41(5):324-33. DOI: 10.1053/j.semnuclmed.2011.05.003. View

Wu M, Liu F, Lin K, Sun J, Chen S . Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan. Nucl Med Commun. 2019; 40(6):568-575. PMC: 6553523. DOI: 10.1097/MNM.0000000000000987. View

DellAversana S, Coppola M, Balestrieri U, Mainenti P, Pascale C, Imbriaco M . Integrated Imaging Characterization of Adrenal Adenoma: False-Positive Metaiodobenzylguanidine (MIBG) Findings of Adrenal Scintigraphy. Pol J Radiol. 2018; 82:422-425. PMC: 5894017. DOI: 10.12659/PJR.901853. View

10.

Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A . Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016; 175(2):G1-G34. DOI: 10.1530/EJE-16-0467. View

11.

Feggi L, Degli Uberti E, Pansini G, Transforini G, Prandini N, Ambrosio M . Pitfalls in scintigraphic detection of neuroendocrine tumours. Eur J Nucl Med. 1992; 19(3):214-8. DOI: 10.1007/BF00173284. View

12.

Blake M, Cronin C, Boland G . Adrenal imaging. AJR Am J Roentgenol. 2010; 194(6):1450-60. DOI: 10.2214/AJR.10.4547. View

13.

Lugat A, Drui D, Mirallie E, Kraeber-Bodere F, Ansquer C . 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma. Clin Nucl Med. 2019; 44(9):738-740. DOI: 10.1097/RLU.0000000000002736. View

14.

Havekes B, King K, Lai E, Romijn J, Corssmit E, Pacak K . New imaging approaches to phaeochromocytomas and paragangliomas. Clin Endocrinol (Oxf). 2009; 72(2):137-45. PMC: 2966973. DOI: 10.1111/j.1365-2265.2009.03648.x. View

15.

Yen R, Wu V, Liu K, Cheng M, Wu Y, Chueh S . 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results. J Nucl Med. 2009; 50(10):1631-7. DOI: 10.2967/jnumed.109.064873. View

16.

Zettinig G, Mitterhauser M, Wadsak W, Becherer A, Pirich C, Vierhapper H . Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging. 2004; 31(9):1224-30. DOI: 10.1007/s00259-004-1575-0. View

17.

Low G, Dhliwayo H, Lomas D . Adrenal neoplasms. Clin Radiol. 2012; 67(10):988-1000. DOI: 10.1016/j.crad.2012.02.005. View

18.

dAmuri F, Maestroni U, Pagnini F, Russo U, Melani E, Ziglioli F . Magnetic resonance imaging of adrenal gland: state of the art. Gland Surg. 2019; 8(Suppl 3):S223-S232. PMC: 6755942. DOI: 10.21037/gs.2019.06.02. View

19.

Kekalainen P, Alhava E, Vanninen E, Niskanen L . A pitfall of metaiodobenzylguanidine scan: paraganglioma in close proximity to adrenocortical adenoma. Exp Clin Endocrinol Diabetes. 2003; 111(5):294-7. DOI: 10.1055/s-2003-41288. View

20.

Murayama R, Nishie A, Hida T, Baba S, Inokuchi J, Oda Y . Uptake of 18F-FDG in Adrenal Adenomas Is Associated With Unenhanced CT Value and Constituent Cells. Clin Nucl Med. 2019; 44(12):943-948. DOI: 10.1097/RLU.0000000000002759. View